增强T/NK细胞抗肿瘤免疫治疗的小结构大方案  

Small structures as big solutions to T/NK cells based anti-tumor immunotherapy

作　　者：王婷婷 张浩 韩要宝 韩孟晓 李桢 Tingting Wang;Hao Zhang;Yaobao Han;Mengxiao Han;Zhen Li(Center for Molecular Imaging and Nuclear Medicine,State Key Laboratory of Radiation Medicine and Protection,School for Radiological and Interdisciplinary Sciences(RAD-X),Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,Soochow University,Suzhou 215123,China)

机构地区：[1]Center for Molecular Imaging and Nuclear Medicine,State Key Laboratory of Radiation Medicine and Protection,School for Radiological and Interdisciplinary Sciences(RAD-X),Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,Soochow University,Suzhou 215123,China

出　　处：《Science Bulletin》2024年第4期437-440,共4页科学通报（英文版）

基　　金：the support from the National Natural Science Foundation of China(81971671,82101927,and 32101110);the National Key Research and Development Program of China(2022YFA1104300);the Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions(22KJA310004);China Postdoctoral Science Foundation(2020M681720);Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University(YXY2303025);the Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection;the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD).

摘　　要：The anti-tumor immunotherapy is primarily reliant on the host’s own immune system.After treatment with immunotherapy,the tumor can be inhibited for a longer term potentially or even cured completely because of the systemic immunotherapy response.This response can trigger a long-term memory to inhibit the recurrence and malignant progression of tumor.

关 键 词：inhibited IMMUNOTHERAPY TUMOR 

分 类 号：R730.51[医药卫生—肿瘤]